Papers
27
Total Citations
665
H-Index
14
About
Michele Marchioni is a leading urologic surgeon and researcher whose work is reshaping the surgical management of kidney and prostate cancers. His primary research focuses on advancing minimally invasive techniques, particularly robot-assisted and single-port partial nephrectomy, where he has made landmark contributions. Marchioni has systematically defined best practices for tumor resection techniques during robotic partial nephrectomy, demonstrating how these approaches optimize oncologic control while preserving renal function. His meta-analyses—including a 2020 study on robot-assisted radical nephrectomy (118 citations) and a 2022 analysis of 3D model-assisted partial nephrectomy (84 citations)—have become essential references for surgeons worldwide. Beyond kidney surgery, Marchioni has critically evaluated postoperative quality of life, authoring systematic reviews on managing urinary incontinence and erectile dysfunction following robot-assisted radical prostatectomy. His work on the Trifecta and Pentafecta outcomes has established new benchmarks for surgical success. Through the ROSULA Collaborative Group, he has led large multi-institutional analyses that provide robust, real-world evidence. With over 500 total citations and a growing portfolio of high-impact systematic reviews, Marchioni is a trusted voice in evidence-based urologic oncology, guiding the next generation of surgeons toward safer, more effective, and less invasive treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review56 citations · 2023
- 4
- 5
- 6
- 7
- 8
- 9
- 10